Quarterly report pursuant to Section 13 or 15(d)

Organization and Business Operations (Details Textual)

v2.4.0.6
Organization and Business Operations (Details Textual) (USD $)
3 Months Ended 6 Months Ended 83 Months Ended
Jun. 30, 2012
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Proceeds from Related Party Debt       $ 92,717
Proceeds from exercise of warrants   2,468,250 0 2,468,250
Estimated Cost Of Clinical Trial Lab   $ 1,500,000    
Cash Basis Warrants Exercise Price Reduction Percentage 25.00%